• 453 Citations
  • 13 h-Index
19992019
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 8 Similar Profiles
Apoptosis Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Caspases Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Melanoma Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
Lymphocytes Medicine & Life Sciences
Cell Death Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

  • 453 Citations
  • 13 h-Index
  • 38 Article

Exploring differential connexin expression across melanocytic tumor progression involving the tumor microenvironment

Kiszner, G., Balla, P., Wichmann, B., Barna, G., Baghy, K., Nemeth, I. B., Varga, E., Furi, I., Tóth, B. & Krenács, T., febr. 1 2019, In : Cancers. 11, 2, 165.

Research output: Article

Open Access
Connexins
Tumor Microenvironment
Connexin 43
Melanoma
Melanocytes
2 Citations (Scopus)

In contrast to high CD49d, low CXCR4 expression indicates the dependency of chronic lymphocytic leukemia (CLL) cells on the microenvironment

Kriston, C., Plander, M., Márk, Á., Sebestyén, A., Bugyik, E., Matolcsy, A. & Barna, G., jún. 28 2018, (Accepted/In press) In : Annals of Hematology. p. 1-8 8 p.

Research output: Article

Cellular Microenvironment
B-Cell Chronic Lymphocytic Leukemia
Apoptosis
Vascular Cell Adhesion Molecule-1
Mesenchymal Stromal Cells

Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas

Németh, K., Szücs, N., Czirják, S., Reiniger, L., Szabó, B., Barna, G., Karászi, K., Igaz, P., Zivkovic, V., Korbonits, M., Patócs, A. & Butz, H., jún. 26 2018, In : Oncotarget. 9, 49, p. 29180-29192 13 p.

Research output: Article

Pituitary Neoplasms
Aspirin
TNF-Related Apoptosis-Inducing Ligand
Cyclin-Dependent Kinase 2
Therapeutics